Deutsche Bank’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.5K | Sell |
12,203
-21,386
| -64% | -$160K | ﹤0.01% | 3282 |
|
|
2025
Q1 | $286K | Hold |
33,589
| – | – | ﹤0.01% | 2758 |
|
|
2024
Q4 | $1.2M | Sell |
33,589
-30,258
| -47% | -$1.08M | ﹤0.01% | 2115 |
|
|
2024
Q3 | $3.02M | Buy |
63,847
+807
| +1% | +$38.1K | ﹤0.01% | 1498 |
|
|
2024
Q2 | $3.17M | Sell |
63,040
-371
| -0.6% | -$18.6K | ﹤0.01% | 1402 |
|
|
2024
Q1 | $7.1M | Buy |
63,411
+17,842
| +39% | +$2M | ﹤0.01% | 1129 |
|
|
2023
Q4 | $2.64M | Buy |
45,569
+43,056
| +1,713% | +$2.5M | ﹤0.01% | 1516 |
|
|
2023
Q3 | $79.8K | Sell |
2,513
-42,997
| -94% | -$1.37M | ﹤0.01% | 3231 |
|
|
2023
Q2 | $3.74M | Sell |
45,510
-392
| -0.9% | -$32.2K | ﹤0.01% | 1340 |
|
|
2023
Q1 | $4.72M | Buy |
45,902
+674
| +1% | +$69.3K | ﹤0.01% | 1264 |
|
|
2022
Q4 | $6.63M | Buy |
45,228
+474
| +1% | +$69.4K | ﹤0.01% | 1114 |
|
|
2022
Q3 | $7.56M | Sell |
44,754
-235
| -0.5% | -$39.7K | ﹤0.01% | 1055 |
|
|
2022
Q2 | $5.2M | Sell |
44,989
-1,238
| -3% | -$143K | ﹤0.01% | 1261 |
|
|
2022
Q1 | $4.61M | Buy |
46,227
+43,147
| +1,401% | +$4.3M | ﹤0.01% | 1457 |
|
|
2021
Q4 | $479K | Sell |
3,080
-1,088
| -26% | -$169K | ﹤0.01% | 2864 |
|
|
2021
Q3 | $982K | Sell |
4,168
-3,685
| -47% | -$868K | ﹤0.01% | 2615 |
|
|
2021
Q2 | $2.67M | Sell |
7,853
-923
| -11% | -$313K | ﹤0.01% | 1959 |
|
|
2021
Q1 | $3.55M | Sell |
8,776
-291
| -3% | -$118K | ﹤0.01% | 1767 |
|
|
2020
Q4 | $6.03M | Sell |
9,067
-25,538
| -74% | -$17M | ﹤0.01% | 1264 |
|
|
2020
Q3 | $16.1M | Buy |
34,605
+32,272
| +1,383% | +$15M | 0.01% | 780 |
|
|
2020
Q2 | $1.37M | Buy |
2,333
+1,886
| +422% | +$1.1M | ﹤0.01% | 2021 |
|
|
2020
Q1 | $65K | Sell |
447
-29
| -6% | -$4.22K | ﹤0.01% | 3362 |
|
|
2019
Q4 | $68K | Sell |
476
-1,726
| -78% | -$247K | ﹤0.01% | 3697 |
|
|
2019
Q3 | $86K | Sell |
2,202
-618
| -22% | -$24.1K | ﹤0.01% | 3550 |
|
|
2019
Q2 | $285K | Sell |
2,820
-4,323
| -61% | -$437K | ﹤0.01% | 3568 |
|
|
2019
Q1 | $938K | Buy |
7,143
+6,477
| +973% | +$851K | ﹤0.01% | 3014 |
|
|
2018
Q4 | $67K | Sell |
666
-606
| -48% | -$61K | ﹤0.01% | 4170 |
|
|
2018
Q3 | $318K | Buy |
1,272
+35
| +3% | +$8.75K | ﹤0.01% | 3941 |
|
|
2018
Q2 | $552K | Buy |
1,237
+552
| +81% | +$246K | ﹤0.01% | 3734 |
|
|
2018
Q1 | $269K | Buy |
685
+229
| +50% | +$89.9K | ﹤0.01% | 3936 |
|
|
2017
Q4 | $187K | Buy |
456
+118
| +35% | +$48.4K | ﹤0.01% | 3889 |
|
|
2017
Q3 | $144K | Buy |
338
+186
| +122% | +$79.2K | ﹤0.01% | 3868 |
|
|
2017
Q2 | $53K | Buy |
+152
| New | +$53K | ﹤0.01% | 4103 |
|